Esmé Waanders

3.7k citations

42 papers · 1.4k indexed · h-index 21

Hematology top 2%
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 5
Public Health, Environmental and Occupational Health top 2%
- Acute Lymphoblastic Leukemia research 16
Pediatrics, Perinatology and Child Health top 5%
- Childhood Cancer Survivors' Quality of Life 5
Genetics top 10%
- Genetic and Kidney Cyst Diseases 9
Cancer Research
Molecular Biology
- Cancer-related gene regulation 6
- Epigenetics and DNA Methylation 5
Surgery
- Pediatric Hepatobiliary Diseases and Treatments 5

Co-authors: Roland P. Kuiper Peter M. Hoogerbrugge Frank N. van Leeuwen Patrick J. Keeling James Harper Joost P.H. Drenth Ad Geurts van Kessel Vincent H. J. van der Velden
Cited by: Hematology Public Health, Environmental and Occupational Health Pediatrics, Perinatology and Child Health
Journals: Blood (10 papers)Leukemia (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Esmé Waanders

41 papers receiving 1.4k citations

Peers

Countries citing papers authored by Esmé Waanders

Since Specialization

Citations

This map shows the geographic impact of Esmé Waanders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmé Waanders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmé Waanders more than expected).

Fields of papers citing papers by Esmé Waanders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmé Waanders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmé Waanders. The network helps show where Esmé Waanders may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Esmé Waanders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esmé Waanders Line = papers co-authored together Esmé Waanders links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL JCO Precision Oncology ·Judith M. Boer,Marco J. Koudijs,Lennart Kester,Edwin Sonneveld,Jayne Y. Hehir‐Kwa,Simone Snijder,Esmé Waanders,Arjan Buijs,Válerie de Haas,Inge M. van der Sluis,Rob Pieters,Monique L. den Boer,Bastiaan B.J. Tops	2025	1
2	Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic Tests Blood ·正次相良,Golam Muin Uddin,DI Toro Massimo,Wouter W. van Solinge,Eduard J. van Beers,Marije Bartels,Esmé Waanders,Minke A.E. Rab,Richard van Wijk	2023	1
3	Optical genome mapping identifies a germline retrotransposon insertion in SMARCB1 in two siblings with atypical teratoid rhabdoid tumors The Journal of Pathology ·Mariangela Sabatella,Tuomo Mantere,Esmé Waanders,Kornelia Neveling,Arjen R. Mensenkamp,Freerk van Dijk,Jayne Y. Hehir‐Kwa,H. Harms,Michael Kwint,Н.С. Братчикова,Felipe Antonio,Corrie Gidding,Maarten H. Lequin,Benno Küsters,Pieter Wesseling,Marcel Nelen,Angeline H. Murphy,Alexander Hoischen,Marjolijn C.J. Jongmans,Roland P. Kuiper	2021	28
4	Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma Familial Cancer ·真美森本,Freerk van Dijk,Esmé Waanders,Arjan Buijs,Marijn A. Vermeulen,Jan Loeffen,Roland P. Kuiper,Marjolijn C.J. Jongmans	2021	4
5	Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing Leukemia & lymphoma ·Jiangyan Yu,Željko Antić,Simon V. van Reijmersdal,Alexander Hoischen,Edwin Sonneveld,Esmé Waanders,Roland P. Kuiper	2017	5
6	Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences Leukemia ·Esmé Waanders,Blanca Scheijen,Marjolijn C.J. Jongmans,Hanka Venselaar,Simon V. van Reijmersdal,Ф. Ш. Амаева,Agata Pastorczak,Robbert D.A. Weren,C. Ellen van der Schoot,J. W. Van Niekerk,Edwin Sonneveld,Nicoline Hoogerbrugge,Vincent H. J. van der Velden,Bernd Gruhn,Peter M. Hoogerbrugge,Jacques J. M. van Dongen,Ad Geurts van Kessel,Frank N. van Leeuwen,Roland P. Kuiper	2016	38
7	Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool European Journal of Medical Genetics ·Marjolijn C.J. Jongmans,Jan Loeffen,Esmé Waanders,Peter M. Hoogerbrugge,Marjolijn J. L. Ligtenberg,Roland P. Kuiper,Nicoline Hoogerbrugge	2016	104
8	Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition British Journal of Cancer ·Illja J. Diets,Irıs D. Nagtegaal,Jan Loeffen,Ivo de Blaauw,Esmé Waanders,Nicoline Hoogerbrugge,Marjolijn C.J. Jongmans	2016	23
9	Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL Blood ·Arian van der Veer,Esmé Waanders,Rob Pieters,Marieke E. Willemse,Simon V. van Reijmersdal,Lisa J. Russell,Christine J. Harrison,William E. Evans,Vincent H. J. van der Velden,Peter M. Hoogerbrugge,Frank N. van Leeuwen,Gabriele Escherich,Martin A. Horstmann,Larissa Gomes Espinosa,Dimitris Rizopoulos,Hester A. de Groot‐Kruseman,Edwin Sonneveld,Roland P. Kuiper,Monique L. den Boer	2013	187
10	The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution PLoS Genetics ·Esmé Waanders,Blanca Scheijen,Laurens T. van der Meer,Simon V. van Reijmersdal,Liesbeth van Emst,Yvet Kroeze,Edwin Sonneveld,Peter M. Hoogerbrugge,Ad Geurts van Kessel,Frank N. van Leeuwen,Roland P. Kuiper	2012	59
11	Late Recurrence of Childhood T-Cell Acute Lymphoblastic Leukemia Frequently Represents a Second Leukemia Rather Than a Relapse: First Evidence for Genetic Predisposition Journal of Clinical Oncology ·Tomasz Szczepański,Vincent H. J. van der Velden,Esmé Waanders,Roland P. Kuiper,Pieter Van Vlierberghe,Bernd Gruhn,Cornelia Eckert,Renate Panzer‐Grümayer,Giuseppe Basso,Hélène Cavé,Udo zur Stadt,Dario Campana,André Schrauder,Rosemary Sutton,Margarita Garrido,Jules P.P. Meijerink,Jacques J. M. van Dongen	2011	51
12	Microarray‐based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia Genes Chromosomes and Cancer ·Annet Simons,Marian Stevens‐Kroef,Pedro Renóm y Riera,Najmi Qolbiyah,Daniël Olde Weghuis,Eva van den Berg,Esmé Waanders,Peter M. Hoogerbrugge,Roland P. Kuiper,Ad Geurts van Kessel	2011	16
13	Secondary, Somatic Mutations Might Promote Cyst Formation in Patients With Autosomal Dominant Polycystic Liver Disease Gastroenterology ·Manoe J. Janssen,Esmé Waanders,René H. M. te Morsche,Ruoyu Xing,Henry Dijkman,Jannes Woudenberg,Joost P.H. Drenth	2011	32
14	Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia Leukemia ·Esmé Waanders,Vincent H. J. van der Velden,C. Ellen van der Schoot,Frank N. van Leeuwen,Simon V. van Reijmersdal,Válerie de Haas,A. Veerman,Ad Geurts van Kessel,Peter M. Hoogerbrugge,Roland P. Kuiper,Jacques J. M. van Dongen	2010	91
15	IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL Leukemia ·Roland P. Kuiper,Esmé Waanders,Vincent H. J. van der Velden,بن المحبوبي,Ramprasath Venkatachalam,Blanca Scheijen,Edwin Sonneveld,Jacques J. M. van Dongen,A. Veerman,Frank N. van Leeuwen,Ad Geurts van Kessel,Peter M. Hoogerbrugge	2010	196
16	Carbohydrate antigen 19‐9 is extremely elevated in polycystic liver disease Liver International ·Esmé Waanders,Loes van Keimpema,Johannes T. Brouwer,Martijn G.H. van Oijen,Raymond Aerts,Fred C.G.J. Sweep,Frederik Nevens,Joost P.H. Drenth	2009	58
17	Congenital disorders of glycosylation in hepatology: The example of polycystic liver disease Journal of Hepatology ·Manoe J. Janssen,Esmé Waanders,Jannes Woudenberg,Dirk J. Lefeber,Joost P.H. Drenth	2009	38
18	Cysts of PRKCSH mutated polycystic liver disease patients lack hepatocystin but express Sec63p Histochemistry and Cell Biology ·Esmé Waanders,Huib J. E. Croes,Cathy Maass,René H. M. te Morsche,F. H. D. de Souza,J. Han van Krieken,Jack Fransen,Joost P.H. Drenth	2008	20
19	Disrupted cell adhesion but not proliferation mediates cyst formation in polycystic liver disease Modern Pathology ·Esmé Waanders,J. Han van Krieken,Anke L. Lameris,Joost P.H. Drenth	2008	22
20	Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations Human Mutation ·Kavya Mishra,Pieter van der Vlies,Marcel F. Jonkman,Esmé Waanders,Charles H.C.M. Buys,Hans Scheffer	2003	38

About Esmé Waanders

Esmé Waanders is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Cancer Research and Pediatrics, Perinatology and Child Health, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (16 papers), Genetic and Kidney Cyst Diseases (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Cancer-related gene regulation (6 papers), Acute Myeloid Leukemia Research (5 papers), Childhood Cancer Survivors' Quality of Life (5 papers), Epigenetics and DNA Methylation (5 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). The work is most often cited by research in Hematology (514 citations), Public Health, Environmental and Occupational Health (648 citations), Pediatrics, Perinatology and Child Health (383 citations), Genetics (330 citations) and Cancer Research (118 citations). Esmé Waanders has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Roland P. Kuiper, Peter M. Hoogerbrugge, Frank N. van Leeuwen, Patrick J. Keeling, James Harper, Joost P.H. Drenth, Ad Geurts van Kessel, Vincent H. J. van der Velden, Edwin Sonneveld and Simon V. van Reijmersdal. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Journal of Hepatology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact